T Cells and B Cells in Lupus Nephritis

Seminars in Nephrology

Volumn 27, Issue 1, 2007, Pages 47-58

  Foster, Mary H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

autoimmunity; immune regulation; immunotherapy; Lupus nephritis; tolerance

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD7 ANTIGEN; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A ANTAGONIST; CPG OLIGODEOXYNUCLEOTIDE; CRRY FC FUSION PROTEIN; DOUBLE STRANDED DNA; HYBRID PROTEIN; MONOCLONAL ANTIBOD ICOSL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C5; MONOCLONAL ANTIBODY CD19; MONOCLONAL ANTIBODY CD20; MONOCLONAL ANTIBODY CD22; OLIGOMER; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; DENDRITIC CELL; DISEASE COURSE; DISEASE PREDISPOSITION; DNA METHYLATION; DRUG TARGETING; EFFECTOR CELL; ENVIRONMENTAL FACTOR; GENETIC RISK; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE FUNCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; CYTOKINES; HUMANS; IMMUNE TOLERANCE; LUPUS NEPHRITIS; T-LYMPHOCYTES;

EID: 33847277400     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2006.09.007     Document Type: Article

References (70)

1. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., and Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science 301 (2003) 1374-1377
2. Jacobi A.M., and Diamond B. Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus. J Exp Med. 202 (2005) 341-344
3. Goodnow C., Sprent J., Fazekas de St Groth B., and Vinuesa C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435 (2005) 590-597
4. Keir M., and Sharpe A. The B7/CD28 costimulatory family in autoimmunity. Immunol Rev. 204 (2005) 128-143
5. Peng S. Signaling in B cells via Toll-like receptors. Curr Opin Immunol. 17 (2005) 230-236
6. Rao T., and Richardson B. Environmentally induced autoimmune diseases: potential mechanisms. Environ Health Perspect. 107 Suppl 5 (1999) 737-742
7. Lauwerys B., and Wakeland E. Genetics of lupus nephritis. Lupus 14 (2005) 2-12
8. Yung R., Powers D., Johnson K., Amento E., Carr D., Laing T., et al. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupus-like disease in syngeneic mice. J Clin Invest. 97 (1996) 2866-2871
9. Kretz-Rommel A., and Rubin R. Disruption of positive selection of thymocytes causes autoimmunity. Nat Med. 6 (2000) 298-305
10. Prigent P., Saoudi A., Pannetier C., Graber P., Bonnefoy J.Y., Druet P., et al. Mercuric chloride, a chemical responsible for T helper cell (TH)2-mediated autoimmunity in Brown Norway rats, directly triggers T cells to produce interleukin-4. J Clin Invest. 96 (1995) 1484-1489
11. Kono D.H., Balomenos D., Pearson D.L., Park M.S., Hildebrandt B., Hultman P., et al. The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. J Immunol. 161 (1998) 234-240
12. Erikson J., Mandik L., Bui A., Eaton A., Noorchashm H., Nguyen K.A., et al. Self-reactive B cells in nonautoimmune and autoimmune mice. Immunol Res. 17 (1998) 49-61
13. Michaels M., Kang H., Kaliyaperumal A., Satyaraj E., Shi Y., and Datta S.K. A defect in deletion of nucleosome-specific autoimmune T cells in lupus-prone thymus: role of thymic dendritic cells. J Immunol. 175 (2005) 5857-5865
14. Nagy G., Koncz A., and Perl A. T- and B-cell abnormalities in systemic lupus erythematosus. Crit Rev Immunol. 25 (2005) 123-140
15. Hoffman R.W. T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol. 113 (2004) 4-13
16. Zielinski C., Jacob S., Bouzahzah F., Ehrlich B., and Craft J. Naive CD4+ T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyperproliferation due to intrinsic threshold defects in activation. J Immunol. 174 (2005) 5100-5109
17. Xu L., Zhang L., Yi Y., Kang H.K., and Datta S.K. Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat Med. 10 (2004) 411-415
18. Grammer A.C., and Lipsky P.E. B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther. 5 Suppl 4 (2003) S22-S27
19. Renaudineau Y., Pers J.O., Bendaoud B., Jamin C., and Youinou P. Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev. 3 (2004) 516-523
20. Tsubata T. B cell abnormality and autoimmune disorders. Autoimmunity 38 (2005) 331-337
21. Mackay F., Sierro F., Grey S., and Gordon T.P. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun. 8 (2005) 243-265
22. Thien M., Phan T., Gardam S., Amesbury M., Basten A., Mackay F., et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20 (2004) 785-798
23. Sekine H., Watanabe H., and Gilkeson G.S. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol. 172 (2004) 3913-3921
24. Kelley V.R., Diaz-Gallo C., Jevnikar A.M., and Singer G.G. Renal tubular epithelial and T cell interactions in autoimmune renal disease. Kidney Int. 39 (1993) S108-S115
25. Yokoyama H., Zheng X., Strom T., and Kelley V.R. B7(+)-transfectant tubular epithelial cells induce T cell anergy, ignorance or proliferation. Kidney Int. 45 (1994) 1105-1112
26. Kyttaris V.C., and Tsokos G.C. T lymphocytes in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 16 (2004) 548-552
27. Datta S. Major peptide autoepitopes for nucleosome-centered T and B cell interaction in human and murine lupus. Ann N Y Acad Sci. 987 (2003) 79-90
28. Peng S. Experimental use of murine lupus models. Methods Mol Med. 102 (2004) 227-272
29. Jevnikar A.M., Grusby M.J., and Glimcher L.H. Prevention of nephritis in major histocompatibility complex class-II-deficient MRL-lpr mice. J Exp Med. 179 (1994) 1137-1143
30. Daikh D.I., Finck B.K., Linsley P.S., Hollenbaugh D., and Wofsy D. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol. 159 (1997) 3104-3108
31. Kinoshita K., Tesch G., Schwarting A., Maron R., Sharpe A.H., and Kelley V.R. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J Immunol. 164 (2000) 6046-6056
32. Iwai H., Abe M., Hirose S., Tsushima F., Tezuka K., Akiba H., et al. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol. 171 (2003) 2848-2854
33. Zeller G., Hirahashi J., Schwarting A., Sharpe A.H., and Kelley V.R. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus. J Am Soc Nephrol. 17 (2006) 122-130
34. Peng S.L., Madaio M.P., Hughes D.P.M., Crispe I.N., Owen M.J., Wen L., et al. Murine lupus in the absence of αβ T cells. J Immunol. 156 (1996) 4041-4049
35. Christianson G.J., Blankenburg R.L., Duffy T.M., Panka D., Roths J.B., Marshak-Rothstein A., et al. Beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. J Immunol. 156 (1996) 4932-4939
36. Chan O., Paliwal V., McNiff J., Park S.H., Bendelac A., and Shlomchik M.J. Deficiency in beta(2)-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRL-Fas(lpr) mice: an example of disease regulation at the organ level. J Immunol. 167 (2001) 2985-2990
37. Mozes E., Lovchik J., Zinger H., and Singer D.S. MHC class I expression regulates susceptibility to spontaneous autoimmune disease in (NZBxNZW)F1 mice. Lupus 14 (2005) 308-314
38. Merino R., Fossati L., Iwamoto M., Takahashi S., Lemoine R., Ibnou-Zekri N., et al. Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice. J Autoimmun. 8 (1995) 33-45
39. Adachi Y., Inaba M., Sugihara A., Koshiji M., Sugiura K., Amoh Y., et al. Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW x BXSB)F1 mice. Immunobiology 198 (1998) 451-464
40. Kapp J., Kapp L., and McKenna K. Gammadelta T cells play an essential role in several forms of tolerance. Immunol Res. 29 (2004) 93-102
41. Peng S.L., Madaio M.P., Hayday A.C., and Craft J. Propagation and regulation of systemic autoimmunity by γδ T cells. J Immunol. 157 (1996) 5689-5698
42. Forestier C., Molano A., Im J., Dutronc Y., Diamond B., Davidson A., et al. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice. J Immunol. 175 (2005) 763-770
43. La Cava A., Fang C., Singh R., Ebling F., and Hahn B.H. Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun Rev. 4 (2005) 515-519
44. Theofilopoulos A.N., and Dixon F.J. Murine models of systemic lupus erythematosus. Adv Immunol. 37 (1985) 269-390
45. Moore K., Wada T., Barbee S., and Kelley V.R. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(lpr) mice. Kidney Int. 53 (1998) 1631-1641
46. Schwarting A., Tesch G., Kinoshita K., Maron R., Weiner H.L., and Kelley V.R. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol. 163 (1999) 6884-6891
47. Wada T., Schwarting A., Chesnutt M., Wofsy D., and Kelley V.R. Nephritogenic cytokines and disease in MRL-Fas(lpr) kidneys are dependent on multiple T-cell subsets. Kidney Int. 59 (2001) 565-578
48. Kelley V., Diaz-Gallo C., Jevnikar A., and Singer G.G. Renal tubular epithelial and T cell interactions in autoimmune renal disease. Kidney Int Suppl. 39 (1993) S108-S115
49. Meyers C.M., Tomaszewski J.E., Glass J.D., and Chen C.W. The nephritogenic T cell response in murine chronic graft-versus-host disease. J Immunol. 161 (1998) 5321-5330
50. Bailey N.C., and Kelly C.J. Nephritogenic T cells use granzyme C as a cytotoxic mediator. Eur J Immunol. 27 (1997) 2302-2309
51. Peng S., Moslehi J., Robert M., and Craft J. Perforin protects against autoimmunity in lupus-prone mice. J Immunol. 160 (1998) 652-660
52. Foster M.H. Relevance of systemic lupus erythematosus (SLE) nephritis animal models to human disease. Semin Nephrol. 19 (1999) 12-24
53. Mishra N., Reilly C., Brown D., Ruiz P., and Gilkenson G.S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest. 111 (2003) 539-552
54. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
55. Shimizu S., Sugiyama N., Masutani K., Sadanaga A., Miyazaki Y., Inoue Y., et al. Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol. 175 (2005) 7185-7192
56. Kelley V.R., and Wuthrich R.P. Cytokines in the pathogenesis of systemic lupus erythematosus. Semin Nephrol. 19 (1999) 57-66
57. Mizoguchi A., and Bhan A.K. A case for regulatory B cells. J Immunol. 176 (2006) 705-710
58. Shlomchik M.J., Craft J.E., and Mamula M.J. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev. 1 (2001) 147-153
59. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 1 (2000) 475-482
60. Sapir T., and Shoenfeld Y. Facing the enigma of immunomodulatory effects of intravenous immunoglobulin. Clin Rev Allergy Immunol. 29 (2005) 185-199
61. Chan O.T., Madaio M.P., and Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev. 169 (1999) 107-121
62. Ito T., Ishikawa S., Sato T., Akadegawa K., Yurino H., Kitabatake M., et al. Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus. J Immunol. 172 (2004) 3628-3634
63. Su W., and Madaio M. Recent advances in the pathogenesis of lupus nephritis: autoantibodies and B cells. Semin Nephrol. 23 (2003) 564-568
64. Foster M.H. Nephritogenic properties of lupus autoantibodies. In: Lewis E.J., Schwartz M.M., and Korbet S.M. (Eds). Lupus nephritis (1999), Oxford University Press, Oxford 22-78
65. Nimmerjahn F., and Ravetch J. Fcgamma receptors: old friends and new family members. Immunity 24 (2006) 19-28
66. Clynes R., Dumitru C., and Ravetch J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 (1998) 1052-1054
67. Matsumoto K., Watanabe N., Akikusa B., Kurasawa K., Matsumura R., Saito Y., et al. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Arthritis Rheum. 48 (2003) 486-494
68. Bolland S., and Ravetch J. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13 (2000) 277-285
69. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 603-607
70. Prodeus A.P., Goerg S., Shen L.M., Pozdnyakova O.O., Chu L., Alicot E.M., et al. A critical role for complement in maintenance of self-tolerance. Immunity 9 (1998) 721-731